Incyte (INCY) Capital Expenditures (2010 - 2026)

Incyte (INCY) posted Capital Expenditures of $1.6 million for Q1 2026, up 105.09% on a QoQ basis from -$32.1 million in Q4 2025, and down 43.49% year-over-year from $2.9 million in Q1 2025.

Incyte (INCY) Capital Expenditures (2010 - 2026) Analysis & Trends

Incyte's Capital Expenditures history runs 17 years deep, the most recent figure standing at $1.6 million for Q1 2026.

  • Quarterly Capital Expenditures fell 43.49% year-over-year to $1.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.7 million (down 95.86% YoY) and the FY2025 annual result came in at $4.9 million, down 94.29% from the prior year.
  • Capital Expenditures was $1.6 million for Q1 2026 at Incyte, up from -$32.1 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $82.7 million in Q4 2024 and bottomed at -$32.1 million in Q4 2025.
  • A 5-year average of $6.0 million and a median of $1.4 million in 2023 frame the typical range for Capital Expenditures.
  • Peak annual rise in Capital Expenditures reached 22340.52% in 2023, while the deepest fall reached 371.03% in 2023.
  • Incyte's Capital Expenditures stood at -$5.3 million in 2022, then sank by 371.03% to -$25.2 million in 2023, then jumped by 428.7% to $82.7 million in 2024, then plunged by 138.76% to -$32.1 million in 2025, then surged by 105.09% to $1.6 million in 2026.
  • Business Quant data shows INCY's Capital Expenditures at $1.6 million in Q1 2026, -$32.1 million in Q4 2025, and $32.9 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -8,939.03
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 43.25 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 133.40 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 230.60 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 786,000.00
10 Incyte 23.33 Bn 19.32 Bn 1.17 Bn 1.63 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.63 Mn
Mar 31, 2026 1.63 Mn
Dec 31, 2025 -32.06 Mn
Dec 31, 2025 -32.06 Mn
Sep 30, 2025 32.94 Mn
Sep 30, 2025 32.94 Mn
Jun 30, 2025 1.16 Mn
Jun 30, 2025 1.16 Mn
Mar 31, 2025 2.89 Mn
Mar 31, 2025 2.89 Mn
Dec 31, 2024 82.73 Mn
Dec 31, 2024 82.73 Mn
Sep 30, 2024 2.74 Mn
Sep 30, 2024 2.74 Mn
Jun 30, 2024 417,000.00
Jun 30, 2024 417,000.00
Mar 31, 2024 383,000.00
Mar 31, 2024 383,000.00
Dec 31, 2023 -25.17 Mn
Dec 31, 2023 -25.17 Mn